NEW YORK (February 27, 2014) – Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University have named Mark Schoenberg, M.D., professor and university chair of The Department of Urology. Dr. Schoenberg joins from Johns Hopkins Medicine, where he currently serves as The Bernard L. Schwartz Distinguished Professor of Urology and Director of Urologic Oncology. He will assume his new position in April 2014.

Montefiore's Department of Urology is a leader in innovative therapies and advanced surgical and non-surgical treatments. Its physicians and surgeons offer high-quality care and are committed to enhancing current techniques and therapies through research and clinical trials.

"I am pleased to welcome Dr. Schoenberg to Montefiore as Chair of Urology, a distinguished leader in the field with a passionate commitment to research and multi-disciplinary patient care," said Steven M. Safyer, M.D., president and CEO, Montefiore. "Dr. Schoenberg will lead a team with a solid record of clinical, educational and research excellence and build upon this record to continue to advance the care of our patients."

"Dr. Schoenberg's impressive commitment to innovative research makes him an excellent addition to our institutions, which place such great importance on the advancement of techniques and therapies through translational research."

– Dean Allen M. Spiegel, M.D.

During Dr. Schoenberg's 20-year tenure at Johns Hopkins, his clinical practice has centered on the care of patients with all forms of bladder cancer, while his research program focused on the translational validation of urinary markers for the early detection of cancer, the development of regenerative medicine solutions to challenges of lower urinary tract reconstruction after bladder removal surgery and the development of minimally invasive therapies for urologic malignancies. 

"Dr. Schoenberg's impressive commitment to innovative research makes him an excellent addition to our institutions, which place such great importance on the advancement of techniques and therapies through translational research," said Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean at Einstein. "We are truly pleased to welcome Dr. Schoenberg and we look forward to his leadership in this important biomedical field."

Dr. Schoenberg is an active scholar, writer and editor. He is the past chair of the Medical Advisory Board of the Bladder Cancer Advocacy Network, the author of The Guide to Living with Bladder Cancer, co-editor of The Textbook of Bladder Cancer, a contributor to Campbell's Urology and a seminars editor of the journal Urologic Oncology.

"The Department's emphasis on advancing the techniques and therapies for treating urologic diseases through a spectrum of basic, translational and clinical studies is compelling and I look forward to contributing my clinical and research experience to its ongoing success," Dr. Schoenberg said.

Dr. Schoenberg received his Medical Degree (Alpha Omega Alpha) in 1986 from the University of Texas Health Sciences Center and completed his residency in General Surgery and Urology at the Hospital of The University of Pennsylvania in 1992. He served as chief resident and urology instructor at HUP in 1992 before completing basic research and clinical urologic oncology fellowships at Johns Hopkins under the auspices of The American Cancer Society.